Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02051790 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Reader Training Processes
A Phase 4 study, sponsored by Avid Radiopharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 241
- Enrollment target
NCT02051790: Completed Phase 4 study, sponsored by Avid Radiopharmaceuticals.
NCT02051790 is a Phase 4 study that has completed, run by Avid Radiopharmaceuticals. The registered enrollment target is 241 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02051790, a Phase 4 study, has completed, sponsored by Avid Radiopharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 241 participants
- Enrollment target
Study Summary
This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.
Primary Outcome
Agreement between expert panel consensus scan interpretations and clinical practice reader scan interpretations was calculated as a weighted Kappa value across all cases and all clinical practice readers.
Interventions
- DRUG florbetapir F 18
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
What the finished NCT02051790 record still lists
NCT02051790 is an interventional study that assigns participants to a tested intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which florbetapir F 18 is the first listed.
NCT02051790 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02051790 about?
NCT02051790 is a clinical study titled "Evaluation of Reader Training Processes". This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.
What is the current status of trial NCT02051790?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 241 participants. The study started on 2014-03. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02051790?
The interventions under investigation include: florbetapir F 18 (DRUG).
Who is sponsoring clinical trial NCT02051790?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02051790's enrollment target sits among peer trials
241 360th of 2000 higher than 1,641 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01189786 · 241 participants · NA
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
- NCT05050383 · 241 participants · NA
DISE: Phenotyping Obstruction Patterns
- NCT05683418 · 241 participants · Phase 1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
- NCT07213791 · 241 participants · Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia